Schizophrenia drug development may be 'de-risked' with new research tool

News
1
6 Likes
2

Good this must be helpful in finding drugs for negative symptoms…

3

And cognitive symptoms.

1 Like
4

thank you for posting @firemonkey
151519

5

Wow there’s a lot to be thankful for in the news today.

“If the biomarkers are approved by the FDA, the developments of this study will be the first objective biomarkers registered to permit approval of new glutamate-modulating treatments for schizophrenia.”

1 Like